Detection of cancer‐associated cachexia in lung cancer patients using whole‐body [ 18 F]FDG‐PET/CT imaging: A multi‐centre study
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Background: Cancer‐associated cachexia (CAC) is a metabolic syndrome contributing to therapy resistance and mortality in lung cancer patients (LCP). CAC is typically defined using clinical non‐imaging criteria. Given the metabolic underpinnings of CAC and the ability of [ 18 F]fluoro‐2‐deoxy‐D‐glucose (FDG)‐positron emission tomography (PET)/computer tomography (CT) to provide quantitative information on glucose turnover, we evaluate the usefulness of whole‐body (WB) PET/CT imaging, as part of the standard diagnostic workup of LCP, to provide additional information on the onset or presence of CAC. Methods: This multi‐centre study included 345 LCP who underwent WB [ 18 F]FDG‐PET/CT imaging for initial clinical staging. A weight loss grading system (WLGS) adjusted to body mass index was used to classify LCP into ‘No CAC’ (WLGS‐0/1 at baseline prior treatment and at first follow‐up: N = 158, 51F/107M), ‘Dev CAC’ (WLGS‐0/1 at baseline and WLGS‐3/4 at follow‐up: N = 90, 34F/56M), and ‘CAC’ (WLGS‐3/4 at baseline: N = 97, 31F/66M). For each CAC category, mean standardized uptake values (SUV) normalized to aorta uptake (<SUV aorta >) and CT‐defined volumes were extracted for abdominal and visceral organs, muscles, and adipose‐tissue using automated image segmentation of baseline [ 18 F]FDG‐PET/CT images. Imaging and non‐imaging parameters from laboratory tests were compared statistically. A machine‐learning (ML) model was then trained to classify LCP as ‘No CAC’, ‘Dev CAC’, and ‘CAC’ based on their imaging parameters. SHapley Additive exPlanations (SHAP) analysis was employed to identify the key factors contributing to CAC development for each patient. Results: The three CAC categories displayed multi‐organ differences in <SUV aorta >. In all target organs, <SUV aorta > was higher in the ‘CAC’ cohort compared with ‘No CAC’ ( P < 0.01), except for liver and kidneys, where <SUV aorta > in ‘CAC’ was reduced by 5%. The ‘Dev CAC’ cohort displayed a small but significant increase in <SUV aorta > of pancreas (+4%), skeletal‐muscle (+7%), subcutaneous adipose‐tissue (+11%), and visceral adipose‐tissue (+15%). In ‘CAC’ patients, a strong negative Spearman correlation (ρ = −0.8) was identified between <SUV aorta > and volumes of adipose‐tissue. The machine‐learning model identified ‘CAC’ at baseline with 81% of accuracy, highlighting <SUV aorta > of spleen, pancreas, liver, and adipose‐tissue as most relevant features. The model performance was suboptimal (54%) when classifying ‘Dev CAC’ versus ‘No CAC’. Conclusions: WB [ 18 F]FDG‐PET/CT imaging reveals groupwise differences in the multi‐organ metabolism of LCP with and without CAC, thus highlighting systemic metabolic aberrations symptomatic of cachectic patients. Based on a retrospective cohort, our ML model identified patients with CAC with good accuracy. However, its performance in patients developing CAC was suboptimal. A prospective, multi‐centre study has been initiated to address the limitations of the present retrospective analysis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Numerous studies have identified Sc as an independent risk factor for worse postoperative outcomes, reduced tolerance to therapy, and decreased survival in LC patients [4,5,6,7,8].”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [5]
In the citing paper
“CT stands out as the gold standard for muscle mass evaluation, typically performed at the third lumbar vertebra (L3).”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [5]
In the citing paper
“where its estimated prevalence ranges from 40% to 60% [4,5,6]”
From AI-Assistance Body Composition CT at T12 and T4 in Lung Cancer: Diagnosing Sarcopenia, and Its Correlation with Morphofunctional Assessment Techniques (2025) · cites this paper as [5]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia: revised European consensus on definition and diagnosis
Cruz-Jentoft, A. J., Bahat, G., Bauer, J., Boirie, Y., Bruyère, O., Cederholm, T., Cooper, C., Landi, F., Rolland, Y., Sayer, A. A., et al. (2019) · Age and Ageing · doi:10.1093/ageing/afy169 · Cited by 13,818
Mourtzakis, M., Prado, C. M. M., Lieffers, J. R., Reiman, T., McCargar, L. J., & Baracos, V. E. (2008) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/h08-075 · Cited by 2,224
Baracos, V. E., Martin, L., Korc, M., Guttridge, D. C., & Fearon, K. C. H. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2017.105 · Cited by 1,738
ESPEN practical guideline: Clinical Nutrition in cancer
Muscaritoli, M., Arends, J., Bachmann, P., Baracos, V., Barthelemy, N., Bertz, H., Bozzetti, F., Hütterer, E., Isenring, E., Kaasa, S., et al. (2021) · Clinical Nutrition · doi:10.1016/j.clnu.2021.02.005 · Cited by 1,702
Cancer cachexia in adult patients: ESMO Clinical Practice Guidelines☆
Arends, J., Strasser, F., Gonella, S., Solheim, T. S., Madeddu, C., Ravasco, P., Buonaccorso, L., de van der Schueren, M. A. E., Baldwin, C., Chasen, M., et al. (2021) · ESMO Open · doi:10.1016/j.esmoop.2021.100092 · Cited by 586
Inter-organ cross-talk in metabolic syndrome
Priest, C., & Tontonoz, P. (2019) · Nature Metabolism · doi:10.1038/s42255-019-0145-5 · Cited by 279
Research works printed but not linked: 34
- 10.2147/CMAR.S261585 · DOI · Paper page
- 10.1002/jcsm.12402 · DOI · Paper page
- 10.1016/S1470-2045(10)70218-7 · DOI · Paper page
- 10.1002/jcsm.12220 · DOI
- 10.1038/s41571-023-00734-5 · DOI · Paper page
- 10.1038/s41574-018-0123-0 · DOI · Paper page
- 10.1200/JCO.2014.56.1894 · DOI · Paper page
- 10.1186/s13550-021-00834-2 · DOI
- 10.1200/JCO.2012.45.2722 · DOI · Paper page
- 10.1038/s41591-023-02232-8 · DOI
- Beyer T, 2000, A combined PET/CT scanner for clinical oncology, J Nucl Med, 41, 1369
- 10.21037/atm.2018.01.25 · DOI
- Nakamoto R, 2019, Close correlation in cancer patients between diffusely decreased liver uptake on FDG‐PET & cancer‐associated cachexia, J Nucl Med, 60, 217
- 10.1038/s41598-020-77269-7 · DOI · Paper page
- 10.1016/j.clinimag.2018.05.006 · DOI
- 10.1007/s00330‐022‐09226‐z · DOI
- 10.1016/j.jtho.2015.09.009 · DOI · Paper page
- 10.1038/sj.bjc.6606087 · DOI · Paper page
- 10.2967/jnumed.122.264063 · DOI · Paper page
- 10.1016/j.mri.2012.05.001 · DOI · Paper page
- 10.2307/1403797 · DOI · Paper page
- 10.3390/cancers15123111 · DOI
- 10.3322/caac.21660 · DOI · Paper page
- 10.3390/ijms18061216 · DOI
- 10.3892/ol.2021.12531 · DOI
- 10.1016/S0021-9258(18)83822-4 · DOI · Paper page
- 10.1002/cbf.3652 · DOI
- 10.3389/fphys.2021.625417 · DOI
- 10.1177/147323000703500207 · DOI
- 10.1007/s00259‐024‐06689‐8 · DOI
- 10.2967/jnumed.117.196287 · DOI · Paper page
- 10.1016/j.amjsurg.2011.06.053 · DOI
- 10.1016/S0261-5614(03)00098-0 · DOI · Paper page
- Gutschmayer S, 2022, Annual Congress of the European Association of Nuclear Medicine October 15–19, 2022, 225
Cited by
Montero-Benitez, M. Z., Carmona-Llanos, A., Fernández-Jiménez, R., Román-Jobacho, A., Gómez-Millán, J., Modamio-Molina, J., Cabrera-Cesar, E., Vegas-Aguilar, I., Amaya-Campos, M. D. M., Tinahones, F. J., et al. (2025) · Cancers · doi:10.3390/cancers17193255 · Cited by 7
Metadata
- Authors
- Ferrara, D., Abenavoli, E. M., Beyer, T., Gruenert, S., Hacker, M., Hesse, S., Hofmann, L., Pusitz, S., Rullmann, M., Sabri, O., Sciagrà, R., Sundar, L. K. S., Tönjes, A., Wirtz, H., Yu, J., & Frille, A.
- Affiliations
- QIMP Team Medical University of Vienna Vienna Austria
- Division of Nuclear Medicine Azienda Ospedaliero Universitaria Careggi Florence Italy
- Division of Nuclear Medicine Medical University of Vienna Vienna Austria
- Department of Nuclear Medicine University Hospital Leipzig Leipzig Germany
- Department of Endocrinology University Hospital Leipzig Leipzig Germany
- Department of Respiratory Medicine University Hospital Leipzig Leipzig Germany
- Venue
- Journal of Cachexia, Sarcopenia and Muscle
- Publisher
- Wiley
- Published
- 2024-08-27
- Volume
- 15
- Issue
- 6
- Pages
- 2375-2386
- ISSN
- 2190-5991
- 2190-6009
- Cited by
- 19
- References
- 6
- Language
- en
- Funders
- Directorate-General XII, Science, Research, and Development (779282)
- Austrian Science Fund
- Innovationsfonden
- Regione Toscana
- Novartis Foundation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.